Harvard Law School Announces the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

CANNANNEW REPORT

Here’s the press release The Project on Psychedelics Law and Regulation (POPLAR) The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Launched in summer 2021 with a generous grant from the Saisei Foundation, the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Background Despite a longstanding prohibition on psychedelics dating back to the 1970s, scientific and public interest in these substances is growing. Clinical trials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency identified psilocybin as a breakthrough for treatment-resistant depression. These developments indicate that psychedelics may represent substantial improvements over existing treatments for mental illness. While psychedelic therapies make their way through the drug development pipeline, seven U.S. cities and the State of Oregon have decriminalized them, and last November, Oregon voters legalized the supervised administration of psilocybin. At least eight other states are considering similar legislation to legalize or decriminalize psychedelics. Due to their therapeutic and commercial potential, the U.S. market for psychedelics is projected to reach $6.85 billion by 2027, attracting a significant number of for-profit companies and investors. However, despite the proliferation of clinical research centers, increasing private investment in psychedelic drug development, and widespread state and local decriminalization, there is a relative lack of research on the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. POPLAR is the first academic initiative focused on psychedelics law and policy, positioned to be a global leader for research and education in this space.…

Excerpt only …
READ MORE BELOW
Source : Harvard Law School Announces the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.